Skip to content

Reduce the inappropriate use of urinary catheters and intravenous (IV) catheters

Reduce the inappropriate use of urinary and intravenous catheters

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25159
Enrollment
1420
Registered
2016-08-09
Start date
2016-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter- related infection, phlebitis, and bacteremia are associated with an increased morbidity, mortality, and thereby substantial costs. Urinary tract infections is accountable for 40% of all nosocomial infections in Western world hospitals, and 71-80% of these patients had a urinary catheter. Although the incidence of catheter-associated bloodstream infection by peripheral intravenous catheters is low (0.5 per 1000 catheter days), it is important because peripheral intravenous catheters are

Interventions

First we defined a list of appropriate indications for urinary and (peripheral and central) intravenous catheters, which will restrict the use of catheters and urge catheter removal when the indicatio

Sponsors

The Netherlands Organisation for Health Research and Development (ZonMw)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age >18 years old - Patient admitted to internal medicine or subspecialties (gastroenterology & hepatology, geriatrics, pulmonology and rheumatology), or nonsurgical patient admitted to acute medical units - Urinary and/or (peripheral and/or central) intravenous catheter

Exclusion criteria

Exclusion criteria: - Patient who had all catheters prior to admission - Patient admitted for elective short stay - Terminally ill patient

Design outcomes

Primary

MeasureTime frame
Percentage of inappropriate use of urinary and intravenous catheter on the days of data collection.

Secondary

MeasureTime frame
Catheter-related infections or other complications, catheter re-insertion rate, length of hospital (and ICU) stay, mortality, and costs of the de-implementation strategy and the main health care costs.

Contacts

Public ContactBart J Laan

Internal Medicine, Infectious diseases - Academic Medical Center

b.j.laan@amsterdamumc.nlPhone: +31-20-566 6807

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)